Characteristics of insulin therapy of diabetes mellitus type 1 in children and adolescents receiving glucocorticoids

BACKGROUND: In coexistence of diabetes mellitus type 1 (DM1) with severe autoimmune and inflammatory diseases some patients need simultaneous administration of insulin and glucocorticoids (GC). GC therapy in patients with DM1 can worsen glycemic control. AIM: To determine characteristics of insulin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alisa V. Vitebskaya, Anastaiya V. Popovich, Elena Y. Afonina, Yuliya O. Kostina, Karina V. Aleksanyan, Mariya I. Grammatopulo, Ekaterina A. Yablokova, Olga V. Shpitonkova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2019
Materias:
Acceso en línea:https://doaj.org/article/95a794e28bc04cdc8fadbd55762b001c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:95a794e28bc04cdc8fadbd55762b001c
record_format dspace
spelling oai:doaj.org-article:95a794e28bc04cdc8fadbd55762b001c2021-11-14T09:00:22ZCharacteristics of insulin therapy of diabetes mellitus type 1 in children and adolescents receiving glucocorticoids2072-03512072-037810.14341/DM10042https://doaj.org/article/95a794e28bc04cdc8fadbd55762b001c2019-08-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/10042https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378BACKGROUND: In coexistence of diabetes mellitus type 1 (DM1) with severe autoimmune and inflammatory diseases some patients need simultaneous administration of insulin and glucocorticoids (GC). GC therapy in patients with DM1 can worsen glycemic control. AIM: To determine characteristics of insulin therapy of DM1 in children and adolescents receiving GC. DESCRIPTION OF CLINICAL CASES: We observed 5 patients with DM1 receiving GC for juvenile idiopathic arthritis (JIA), juvenile systemic sclerosis (JSS), juvenile dermatomyositis (JDM), ulcerative colitis (UC), and reactive arthritis (RA). Intra-articular administration of GC did not significantly influence glycemic control. In case of GC pulse therapy hyperglycemia and increased insulin requirements were recognized in 3–6 hours after GC receipt, persisted from few hours up to 3 days after each administration. While therapy with oral GC in high doses the worst glycemic control was registered in daylight hours. To overcome insulin resistance change of time of injection and 10%-increase of long-acting insulin analogue, additional injections of ultrashort-acting insulin analogues, temporal prescription of short-acting human insulin were used. While GC therapy insulin daily dose was individual and could reach 2.0 U/kg. After transition to maintaining doses of GC or discontinuation of GC therapy patients returned to standard or relatively low insulin requirements. Levels of glycosylated hemoglobin differed significantly among patients at different stages of treatment, were maximal while long-term therapy with high doses of oral GC, but mostly depended on patient’s compliance. CONCLUSION: Bettering of glycemic control while receiving GC can be reached by timely dose correction of insulin therapy, selection of individual schemes, taking into account time of receipt and pharmacokinetic characteristics of GC. Adherence of the patient and his family to treatment of DM1 plays an important role in glycemic control.Alisa V. VitebskayaAnastaiya V. PopovichElena Y. AfoninaYuliya O. KostinaKarina V. AleksanyanMariya I. GrammatopuloEkaterina A. YablokovaOlga V. ShpitonkovaEndocrinology Research Centrearticlediabetes mellituschildrenglucocorticoidsNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 22, Iss 3, Pp 263-273 (2019)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetes mellitus
children
glucocorticoids
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetes mellitus
children
glucocorticoids
Nutritional diseases. Deficiency diseases
RC620-627
Alisa V. Vitebskaya
Anastaiya V. Popovich
Elena Y. Afonina
Yuliya O. Kostina
Karina V. Aleksanyan
Mariya I. Grammatopulo
Ekaterina A. Yablokova
Olga V. Shpitonkova
Characteristics of insulin therapy of diabetes mellitus type 1 in children and adolescents receiving glucocorticoids
description BACKGROUND: In coexistence of diabetes mellitus type 1 (DM1) with severe autoimmune and inflammatory diseases some patients need simultaneous administration of insulin and glucocorticoids (GC). GC therapy in patients with DM1 can worsen glycemic control. AIM: To determine characteristics of insulin therapy of DM1 in children and adolescents receiving GC. DESCRIPTION OF CLINICAL CASES: We observed 5 patients with DM1 receiving GC for juvenile idiopathic arthritis (JIA), juvenile systemic sclerosis (JSS), juvenile dermatomyositis (JDM), ulcerative colitis (UC), and reactive arthritis (RA). Intra-articular administration of GC did not significantly influence glycemic control. In case of GC pulse therapy hyperglycemia and increased insulin requirements were recognized in 3–6 hours after GC receipt, persisted from few hours up to 3 days after each administration. While therapy with oral GC in high doses the worst glycemic control was registered in daylight hours. To overcome insulin resistance change of time of injection and 10%-increase of long-acting insulin analogue, additional injections of ultrashort-acting insulin analogues, temporal prescription of short-acting human insulin were used. While GC therapy insulin daily dose was individual and could reach 2.0 U/kg. After transition to maintaining doses of GC or discontinuation of GC therapy patients returned to standard or relatively low insulin requirements. Levels of glycosylated hemoglobin differed significantly among patients at different stages of treatment, were maximal while long-term therapy with high doses of oral GC, but mostly depended on patient’s compliance. CONCLUSION: Bettering of glycemic control while receiving GC can be reached by timely dose correction of insulin therapy, selection of individual schemes, taking into account time of receipt and pharmacokinetic characteristics of GC. Adherence of the patient and his family to treatment of DM1 plays an important role in glycemic control.
format article
author Alisa V. Vitebskaya
Anastaiya V. Popovich
Elena Y. Afonina
Yuliya O. Kostina
Karina V. Aleksanyan
Mariya I. Grammatopulo
Ekaterina A. Yablokova
Olga V. Shpitonkova
author_facet Alisa V. Vitebskaya
Anastaiya V. Popovich
Elena Y. Afonina
Yuliya O. Kostina
Karina V. Aleksanyan
Mariya I. Grammatopulo
Ekaterina A. Yablokova
Olga V. Shpitonkova
author_sort Alisa V. Vitebskaya
title Characteristics of insulin therapy of diabetes mellitus type 1 in children and adolescents receiving glucocorticoids
title_short Characteristics of insulin therapy of diabetes mellitus type 1 in children and adolescents receiving glucocorticoids
title_full Characteristics of insulin therapy of diabetes mellitus type 1 in children and adolescents receiving glucocorticoids
title_fullStr Characteristics of insulin therapy of diabetes mellitus type 1 in children and adolescents receiving glucocorticoids
title_full_unstemmed Characteristics of insulin therapy of diabetes mellitus type 1 in children and adolescents receiving glucocorticoids
title_sort characteristics of insulin therapy of diabetes mellitus type 1 in children and adolescents receiving glucocorticoids
publisher Endocrinology Research Centre
publishDate 2019
url https://doaj.org/article/95a794e28bc04cdc8fadbd55762b001c
work_keys_str_mv AT alisavvitebskaya characteristicsofinsulintherapyofdiabetesmellitustype1inchildrenandadolescentsreceivingglucocorticoids
AT anastaiyavpopovich characteristicsofinsulintherapyofdiabetesmellitustype1inchildrenandadolescentsreceivingglucocorticoids
AT elenayafonina characteristicsofinsulintherapyofdiabetesmellitustype1inchildrenandadolescentsreceivingglucocorticoids
AT yuliyaokostina characteristicsofinsulintherapyofdiabetesmellitustype1inchildrenandadolescentsreceivingglucocorticoids
AT karinavaleksanyan characteristicsofinsulintherapyofdiabetesmellitustype1inchildrenandadolescentsreceivingglucocorticoids
AT mariyaigrammatopulo characteristicsofinsulintherapyofdiabetesmellitustype1inchildrenandadolescentsreceivingglucocorticoids
AT ekaterinaayablokova characteristicsofinsulintherapyofdiabetesmellitustype1inchildrenandadolescentsreceivingglucocorticoids
AT olgavshpitonkova characteristicsofinsulintherapyofdiabetesmellitustype1inchildrenandadolescentsreceivingglucocorticoids
_version_ 1718429477455790080